Sangamo Therapeutics
SGMO
SGMO
203 hedge funds and large institutions have $994M invested in Sangamo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $1.22B → $994M (-$227M)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
203
Holding in Top 10
–
Calls
$18.7M
Puts
$12M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$10.6M | |
| 3 | +$10.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.38M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$9.19M | |
| 3 | -$6.81M | |
| 4 |
CC
Casdin Capital
New York
|
-$6.64M |
| 5 |
Renaissance Technologies
New York
|
-$6.43M |